Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

[A Case of Consciousness Disturbance Due to Hyperammonemia Associated with Urinary Tract Infections].

Nakamori H, Fujimura M, Shiraishi T, Sugiyama M, Nishikawa R, Sekita N, Kondo Y, Mikami K.

Hinyokika Kiyo. 2019 May;65(5):163-166. doi: 10.14989/ActaUrolJap_65_5_163. Japanese.

PMID:
31247694
2.

Finger necrosis with eosinophilia and symmetrical occlusion of the peripheral artery.

Nishikawa R, Hirano T, Kawarada O.

Heart Asia. 2019 Jun 5;11(2):e011211. doi: 10.1136/heartasia-2019-011211. eCollection 2019.

3.

Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure.

Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Seko Y, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators.

JAMA Netw Open. 2019 Jun 5;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892.

4.

Repeated spontaneous migration of ureteral stent in hemiplegia patient during ureteral stone treatment.

Sugiyama M, Fujimura M, Nakamori H, Nishikawa R, Sakamoto S, Sekita N, Suzuki H, Mikami K, Ichikawa T.

Urol Case Rep. 2019 Feb 21;24:100854. doi: 10.1016/j.eucr.2019.100854. eCollection 2019 May.

5.

Substitution of the Dimethylamino Group in Gramines and One-Pot Cyclization to Tetrahydro-β-carbolines Using a Triazine-Based Activating Agent.

Fujita H, Nishikawa R, Sasamoto O, Kitamura M, Kunishima M.

J Org Chem. 2019 Jul 5;84(13):8380-8391. doi: 10.1021/acs.joc.9b00039. Epub 2019 Jun 25.

PMID:
31199147
6.

Plasmid-mediated quinolone resistance in Escherichia coli isolates from commercial broiler chickens and selection of fluoroquinolone-resistant mutants.

Nishikawa R, Murase T, Ozaki H.

Poult Sci. 2019 Jun 14. pii: pez337. doi: 10.3382/ps/pez337. [Epub ahead of print]

PMID:
31198966
7.

Intratumoural Immune Cell Landscape in Germinoma Reveals Multipotent Lineages and Exhibits Prognostic Significance.

Takami H, Fukushima S, Aoki K, Satomi K, Narumi K, Hama N, Matsushita Y, Fukuoka K, Yamasaki K, Nakamura T, Mukasa A, Saito N, Suzuki T, Yanagisawa T, Nakamura H, Sugiyama K, Tamura K, Maehara T, Nakada M, Nonaka M, Asai A, Yokogami K, Takeshima H, Iuchi T, Kanemura Y, Kobayashi K, Nagane M, Kurozumi K, Yoshimoto K, Matsuda M, Matsumura A, Hirose Y, Tokuyama T, Kumabe T, Ueki K, Narita Y, Shibui S, Totoki Y, Shibata T, Nakazato Y, Nishikawa R, Matsutani M, Ichimura K; Intracranial Germ Cell Tumor Genome Analysis Consortium (the iGCT Consortium).

Neuropathol Appl Neurobiol. 2019 Jun 10. doi: 10.1111/nan.12570. [Epub ahead of print]

PMID:
31179566
8.

Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.

Toyoda S, Arikawa T, Inami S, Nishikawa R, Saito F, Watanabe R, Sakuma M, Kanaya T, Abe S, Inoue T.

J Cardiovasc Pharmacol. 2019 Jun;73(6):365-372. doi: 10.1097/FJC.0000000000000669.

PMID:
31162245
9.

Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomas.

Nomura M, Saito K, Aihara K, Nagae G, Yamamoto S, Tatsuno K, Ueda H, Fukuda S, Umeda T, Tanaka S, Takayanagi S, Otani R, Nejo T, Hana T, Takahashi S, Kitagawa Y, Omata M, Higuchi F, Nakamura T, Muragaki Y, Narita Y, Nagane M, Nishikawa R, Ueki K, Saito N, Aburatani H, Mukasa A.

Sci Rep. 2019 May 23;9(1):7935. doi: 10.1038/s41598-019-43790-7.

10.

Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts.

Takahashi M, Miki S, Fujimoto K, Fukuoka K, Matsushita Y, Maida Y, Yasukawa M, Hayashi M, Shinkyo R, Kikuchi K, Mukasa A, Nishikawa R, Tamura K, Narita Y, Hamada A, Masutomi K, Ichimura K.

Cancer Sci. 2019 Jul;110(7):2247-2257. doi: 10.1111/cas.14067. Epub 2019 Jun 10.

11.

Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.

Nejo T, Matsushita H, Karasaki T, Nomura M, Saito K, Tanaka S, Takayanagi S, Hana T, Takahashi S, Kitagawa Y, Koike T, Kobayashi Y, Nagae G, Yamamoto S, Ueda H, Tatsuno K, Narita Y, Nagane M, Ueki K, Nishikawa R, Aburatani H, Mukasa A, Saito N, Kakimi K.

Cancer Immunol Res. 2019 Jul;7(7):1148-1161. doi: 10.1158/2326-6066.CIR-18-0599. Epub 2019 May 14.

PMID:
31088845
12.

An Epidermoid Cyst of the Thoracic Spine in an Elderly Patient.

Maeda T, Mishima K, Imanishi J, Shirahata M, Suzuki T, Adachi JI, Sasaki A, Nishikawa R.

World Neurosurg. 2019 Jul;127:113-116. doi: 10.1016/j.wneu.2019.03.262. Epub 2019 Apr 2.

PMID:
30951916
13.

Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome.

Sasaki A, Hirato J, Hirose T, Fukuoka K, Kanemura Y, Hashimoto N, Kodama Y, Ichimura K, Sakamoto H, Nishikawa R.

Brain Tumor Pathol. 2019 Apr;36(2):92-101. doi: 10.1007/s10014-019-00338-x. Epub 2019 Mar 30.

PMID:
30929114
14.

Pattern of recurrence after CyberKnife stereotactic body radiotherapy for peripheral early non-small cell lung cancer.

Nakamura M, Nishikawa R, Mayahara H, Uezono H, Harada A, Hashimoto N, Nishimura H.

J Thorac Dis. 2019 Jan;11(1):214-221. doi: 10.21037/jtd.2018.12.115.

15.

Home Parenteral and Enteral Nutrition During Natural Disasters: A Guide for Clinicians and Consumers.

Ireton-Jones C, Nishikawa K, Nishikawa R.

Nutr Clin Pract. 2019 Apr;34(2):216-219. doi: 10.1002/ncp.10260. Epub 2019 Feb 14. Review.

PMID:
30767286
16.

DNA demethylation is associated with malignant progression of lower-grade gliomas.

Nomura M, Saito K, Aihara K, Nagae G, Yamamoto S, Tatsuno K, Ueda H, Fukuda S, Umeda T, Tanaka S, Takayanagi S, Otani R, Nejo T, Hana T, Takahashi S, Kitagawa Y, Omata M, Higuchi F, Nakamura T, Muragaki Y, Narita Y, Nagane M, Nishikawa R, Ueki K, Saito N, Aburatani H, Mukasa A.

Sci Rep. 2019 Feb 13;9(1):1903. doi: 10.1038/s41598-019-38510-0. Erratum in: Sci Rep. 2019 May 23;9(1):7935.

17.

Genetic influence of cytokine polymorphisms on the clinical outcome of Japanese gastrointestinal cancer patients in palliative care.

Hishida A, Okugawa Y, Morimoto Y, Shirai Y, Okamoto K, Momokita S, Ogawa A, Tanaka K, Nishikawa R, Toiyama Y, Inoue Y, Sakurai H, Urata H, Tanaka M, McMillan DC, Miki C.

Oncol Lett. 2019 Jan;17(1):623-629. doi: 10.3892/ol.2018.9614. Epub 2018 Oct 24.

18.

Polymorphisms in folic acid metabolism genes do not associate with cancer cachexia in Japanese gastrointestinal patients.

Morishita T, Hishida A, Okugawa Y, Morimoto Y, Shirai Y, Okamoto K, Momokita S, Ogawa A, Tanaka K, Nishikawa R, Toiyama Y, Inoue Y, Sakurai H, Urata H, Tanaka M, Miki C.

Nagoya J Med Sci. 2018 Nov;80(4):529-539. doi: 10.18999/nagjms.80.4.529.

19.

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.

Fukuoka K, Kanemura Y, Shofuda T, Fukushima S, Yamashita S, Narushima D, Kato M, Honda-Kitahara M, Ichikawa H, Kohno T, Sasaki A, Hirato J, Hirose T, Komori T, Satomi K, Yoshida A, Yamasaki K, Nakano Y, Takada A, Nakamura T, Takami H, Matsushita Y, Suzuki T, Nakamura H, Makino K, Sonoda Y, Saito R, Tominaga T, Matsusaka Y, Kobayashi K, Nagane M, Furuta T, Nakada M, Narita Y, Hirose Y, Ohba S, Wada A, Shimizu K, Kurozumi K, Date I, Fukai J, Miyairi Y, Kagawa N, Kawamura A, Yoshida M, Nishida N, Wataya T, Yamaoka M, Tsuyuguchi N, Uda T, Takahashi M, Nakano Y, Akai T, Izumoto S, Nonaka M, Yoshifuji K, Kodama Y, Mano M, Ozawa T, Ramaswamy V, Taylor MD, Ushijima T, Shibui S, Yamasaki M, Arai H, Sakamoto H, Nishikawa R, Ichimura K; Japan Pediatric Molecular Neuro-Oncology Group (JPMNG).

Acta Neuropathol Commun. 2018 Dec 4;6(1):134. doi: 10.1186/s40478-018-0630-1.

20.

A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.

Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y, Ichikawa T, Kobayashi H, Fujimaki T, Goto H, Takeshima H, Ueba T, Abe H, Tamiya T, Sonoda Y, Natsume A, Kakuma T, Sugita Y, Komatsu N, Yamada A, Sasada T, Matsueda S, Shichijo S, Itoh K, Terasaki M.

Neuro Oncol. 2019 Feb 19;21(3):348-359. doi: 10.1093/neuonc/noy200.

PMID:
30500939
21.

TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas.

Miyake Y, Adachi JI, Suzuki T, Mishima K, Araki R, Mizuno R, Nishikawa R.

J Neurooncol. 2019 Jan;141(1):131-138. doi: 10.1007/s11060-018-03016-8. Epub 2018 Nov 3.

PMID:
30392088
22.

Demographics, Management, and In-Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan - Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry.

Yaku H, Ozasa N, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Sasaki K, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kato T, Kimura T; KCHF Study Investigators.

Circ J. 2018 Oct 25;82(11):2811-2819. doi: 10.1253/circj.CJ-17-1386. Epub 2018 Sep 26.

23.

Linkage of the ACR National Mammography Database to the Network of State Cancer Registries: Proof of Concept Evaluation by the ACR National Mammography Database Committee.

Zuley ML, Nishikawa RM, Lee CS, Burnside E, Rosenberg R, Sickles EA, Berg W, Leung J, Harvey J, Sengupta D, Gur D.

J Am Coll Radiol. 2019 Jan;16(1):8-14. doi: 10.1016/j.jacr.2018.06.027. Epub 2018 Aug 9.

24.

Evaluation of a Computer-Aided Diagnosis System in the Classification of Lesions in Breast Strain Elastography Imaging.

Marcomini KD, Fleury EFC, Oliveira VM, Carneiro AAO, Schiabel H, Nishikawa RM.

Bioengineering (Basel). 2018 Aug 9;5(3). pii: E62. doi: 10.3390/bioengineering5030062.

25.

Severe panuveitis with relapsing polychondritis.

Masuda N, Nishikawa R, Ueda T, Ogata N.

Am J Ophthalmol Case Rep. 2018 Apr 20;11:3-5. doi: 10.1016/j.ajoc.2018.04.024. eCollection 2018 Sep.

26.

Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.

Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, Arakawa Y, Miyamoto S, Beppu T, Sugiyama K, Nakamura H, Nagane M, Nakasu Y, Hashimoto N, Terasaki M, Matsumura A, Ishikawa E, Wakabayashi T, Iwadate Y, Ohue S, Kobayashi H, Kinoshita M, Asano K, Mukasa A, Tanaka K, Asai A, Nakamura H, Abe T, Muragaki Y, Iwasaki K, Aoki T, Watanabe T, Sasaki H, Izumoto S, Mizoguchi M, Matsuo T, Takeshima H, Hayashi M, Jokura H, Mizowaki T, Shimizu E, Shirato H, Tago M, Katayama H, Fukuda H, Shibui S; Japan Clinical Oncology Group.

J Clin Oncol. 2018 Jun 20:JCO2018786186. doi: 10.1200/JCO.2018.78.6186. [Epub ahead of print]

PMID:
29924704
27.
28.

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.

Ellingson BM, Abrey LE, Garcia J, Chinot O, Wick W, Saran F, Nishikawa R, Henriksson R, Mason WP, Harris RJ, Leu K, Woodworth DC, Mehta A, Raymond C, Chakhoyan A, Pope WB, Cloughesy TF.

Neuro Oncol. 2018 Oct 9;20(11):1525-1535. doi: 10.1093/neuonc/noy064.

29.

BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.

Zhu D, Osuka S, Zhang Z, Reichert ZR, Yang L, Kanemura Y, Jiang Y, You S, Zhang H, Devi NS, Bhattacharya D, Takano S, Gillespie GY, Macdonald T, Tan C, Nishikawa R, Nelson WG, Olson JJ, Van Meir EG.

Cancer Cell. 2018 Jun 11;33(6):1004-1016.e5. doi: 10.1016/j.ccell.2018.05.006.

30.

Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma.

Miki S, Imamichi S, Fujimori H, Tomiyama A, Fujimoto K, Satomi K, Matsushita Y, Matsuzaki S, Takahashi M, Ishikawa E, Yamamoto T, Matsumura A, Mukasa A, Nishikawa R, Masutomi K, Narita Y, Masutani M, Ichimura K.

Cancer Sci. 2018 Jul;109(7):2275-2285. doi: 10.1111/cas.13637. Epub 2018 Jun 19.

31.

A Case of Suspicious Gangliocytoma with Heterogeneously Distributed Lesions in the Thalamus and Basal Ganglia.

Miyake Y, Mishima K, Suzuki T, Adachi JI, Sasaki A, Nishikawa R.

NMC Case Rep J. 2018 Mar 9;5(2):61-64. doi: 10.2176/nmccrj.cr.2017-0169. eCollection 2018 Apr.

32.

Employment status and termination among survivors of pediatric brain tumors: a cross-sectional survey.

Sato I, Higuchi A, Yanagisawa T, Murayama S, Kumabe T, Sugiyama K, Mukasa A, Saito N, Sawamura Y, Terasaki M, Shibui S, Takahashi J, Nishikawa R, Ishida Y, Kamibeppu K.

Int J Clin Oncol. 2018 Oct;23(5):801-811. doi: 10.1007/s10147-018-1279-2. Epub 2018 Apr 30.

PMID:
29713910
33.

Sphingoid Base-Upregulated Caspase-14 Expression Involves MAPK.

Nagahara Y, Kawakami K, Sikandan A, Yagi D, Nishikawa R, Shinomiya T.

Biol Pharm Bull. 2018;41(5):743-748. doi: 10.1248/bpb.b17-00926.

34.

Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.

Nakamura M, Hashimoto N, Mayahara H, Uezono H, Harada A, Nishikawa R, Matsuo Y, Kawaguchi H, Nishimura H.

Radiat Oncol. 2018 Apr 23;13(1):75. doi: 10.1186/s13014-018-1031-0.

35.

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.

Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K, Sievers P, Shimizu H, Nanjo H, Kobayashi Y, Miyake Y, Suzuki T, Adachi JI, Mishima K, Sasaki A, Nishikawa R, Bewerunge-Hudler M, Ryzhova M, Absalyamova O, Golanov A, Sinn P, Platten M, Jungk C, Winkler F, Wick A, Hänggi D, Unterberg A, Pfister SM, Jones DTW, van den Bent M, Hegi M, French P, Baumert BG, Stupp R, Gorlia T, Weller M, Capper D, Korshunov A, Herold-Mende C, Wick W, Louis DN, von Deimling A.

Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23.

PMID:
29687258
36.

Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.

Sanagawa A, Hotta Y, Kataoka T, Maeda Y, Kondo M, Kawade Y, Ogawa Y, Nishikawa R, Tohkin M, Kimura K.

Cancer Med. 2018 Jun;7(6):2269-2279. doi: 10.1002/cam4.1429. Epub 2018 Apr 16.

37.

Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.

Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF.

Neuro Oncol. 2018 Aug 2;20(9):1240-1250. doi: 10.1093/neuonc/noy053.

38.

Rapid and stable production of 2,3-butanediol by an engineered Saccharomyces cerevisiae strain in a continuous airlift bioreactor.

Yamada R, Nishikawa R, Wakita K, Ogino H.

J Ind Microbiol Biotechnol. 2018 May;45(5):305-311. doi: 10.1007/s10295-018-2033-5. Epub 2018 Mar 31.

PMID:
29605870
39.

Malignant disease as a comorbidity in patients with severe aortic stenosis: clinical presentation, outcomes, and management.

Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Nakatsuma K, Kimura Y, Inoko M, Shirai S, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Izumi C, Mitsuoka H, Hirano Y, Sasa T, Nagao K, Inada T, Nishikawa R, Takeuchi Y, Yamagami S, Yamane K, Su K, Komasa A, Ishii K, Yamashita Y, Kato Y, Takabayashi K, Saito N, Minatoya K, Kimura T; CURRENT AS registry Investigators.

Eur Heart J Qual Care Clin Outcomes. 2018 Jul 1;4(3):180-188. doi: 10.1093/ehjqcco/qcy010.

PMID:
29596567
40.

JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG).

J Neurooncol. 2018 Jul;138(3):627-636. doi: 10.1007/s11060-018-2831-7. Epub 2018 Mar 20.

41.

Neutrosophic segmentation of breast lesions for dedicated breast computed tomography.

Lee J, Nishikawa RM, Reiser I, Boone JM.

J Med Imaging (Bellingham). 2018 Jan;5(1):014505. doi: 10.1117/1.JMI.5.1.014505. Epub 2018 Mar 6.

42.

Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.

Nishikawa R, Yoshida K, Ebina Y, Omoteda M, Miyawaki D, Ishihara T, Ejima Y, Akasaka H, Satoh H, Kyotani K, Takahashi S, Sasaki R.

J Radiat Res. 2018 May 1;59(3):316-326. doi: 10.1093/jrr/rry009. Erratum in: J Radiat Res. 2018 May 1;59(3):385.

43.

Locally adaptive decision in detection of clustered microcalcifications in mammograms.

Sainz de Cea MV, Nishikawa RM, Yang Y.

Phys Med Biol. 2018 Feb 15;63(4):045014. doi: 10.1088/1361-6560/aaaa4c.

44.

Automated mammographic breast density estimation using a fully convolutional network.

Lee J, Nishikawa RM.

Med Phys. 2018 Mar;45(3):1178-1190. doi: 10.1002/mp.12763. Epub 2018 Feb 19.

PMID:
29363774
45.

MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.

Huang T, Kim CK, Alvarez AA, Pangeni RP, Wan X, Song X, Shi T, Yang Y, Sastry N, Horbinski CM, Lu S, Stupp R, Kessler JA, Nishikawa R, Nakano I, Sulman EP, Lu X, James CD, Yin XM, Hu B, Cheng SY.

Cancer Cell. 2017 Dec 11;32(6):840-855.e8. doi: 10.1016/j.ccell.2017.11.005.

46.

Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.

Yamada Y, Nishikawa R, Kato M, Okato A, Arai T, Kojima S, Yamazaki K, Naya Y, Ichikawa T, Seki N.

J Hum Genet. 2018 Feb;63(2):195-205. doi: 10.1038/s10038-017-0371-1. Epub 2017 Dec 1.

PMID:
29196733
47.

Importance of Better Human-Computer Interaction in the Era of Deep Learning: Mammography Computer-Aided Diagnosis as a Use Case.

Nishikawa RM, Bae KT.

J Am Coll Radiol. 2018 Jan;15(1 Pt A):49-52. doi: 10.1016/j.jacr.2017.08.027. Epub 2017 Oct 31. No abstract available.

PMID:
29097047
48.

Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio.

Nowosielski M, Ellingson BM, Chinot OL, Garcia J, Revil C, Radbruch A, Nishikawa R, Mason WP, Henriksson R, Saran F, Kickingereder P, Platten M, Sandmann T, Abrey LE, Cloughesy TF, Bendszus M, Wick W.

Neuro Oncol. 2018 Mar 27;20(4):557-566. doi: 10.1093/neuonc/nox162.

49.

Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: 'symptomatic control'.

Nakamura M, Nishimura H, Mayahara H, Uezono H, Harada A, Hashimoto N, Ejima Y, Ishihara T, Nishikawa R, Sasaki R.

J Radiat Res. 2017 Nov 1;58(6):834-839. doi: 10.1093/jrr/rrx042.

50.

Craniospinal Germinomas in Patient with Down Syndrome Successfully Treated with Standard-Dose Chemotherapy and Craniospinal Irradiation: Case Report and Literature Review.

Miyake Y, Adachi JI, Suzuki T, Mishima K, Sasaki A, Nishikawa R.

World Neurosurg. 2017 Dec;108:995.e9-995.e15. doi: 10.1016/j.wneu.2017.09.024. Epub 2017 Sep 12. Review.

PMID:
28919233

Supplemental Content

Loading ...
Support Center